Top Markets
#1 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +593.28%
#2 Phala Phala +59.93%
#3 Bitway Bitway +34.54%
#4 Backpack Backpack +33.40%
#5 龙虾 (Lobster) 龙虾 (Lobster) +25.98%
#6 ARK ARK +24.60%
#7 Mubarak Mubarak +23.76%
#8 The Black Bull The Black Bull +22.66%
#9 Aerodrome Finance Aerodrome Finance +20.05%
#10 PulseChain PulseChain +19.86%
Coin of the day
Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Kedudukan dalam Saham #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Harga Saham
$183.43
Modal Pasaran
$50.54B
Perubahan (1 hari)
2.13%
Perubahan (1 tahun)
29.20%
Negara
US
Perdagangan Becton, Dickinson and Company (BDX)

Kategori

Healthcare
Pendapatan untuk Becton, Dickinson and Company (BDX)
Pendapatan pada Jun 2026 TTM: $1.59B
Menurut laporan kewangan terkini Becton, Dickinson and Company, pendapatan semasa syarikat ialah $1.59B. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $2.01B, peningkatan berbanding pendapatan pada tahun 2023 yang berjumlah $1.66B. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Becton, Dickinson and Company dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $1.59B -15.52%
2025 $1.88B -6.13%
2024 $2.01B 20.64%
2023 $1.66B -6.79%
2022 $1.78B 5.38%
2021 $1.69B 308.70%
2020 $414.00M -64.80%
2019 $1.18B 0.26%
2018 $1.17B 20.18%
2017 $976.00M -9.12%
2016 $1.07B 45.33%
2015 $739.00M -51.45%
2014 $1.52B 30.64%
2013 $1.17B -20.86%
2012 $1.47B -9.02%
2011 $1.62B 3.27%
2010 $1.57B -0.75%
2009 $1.58B 2.61%
2008 $1.54B 27.78%
2007 $1.20B 6.93%
2006 $1.13B 12.05%
2005 $1.00B 33.47%
2004 $752.87M 4.28%
2003 $721.96M 15.06%
2002 $627.47M 8.79%
2001 $576.75M 10.93%
2000 $519.93M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
$3.81B 139.36%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
$4.11B 158.42%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
- -
JP
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
- -
CH
Medline Inc. Medline Inc.
Medline Inc.
MDLN.US
- -
US